DelveInsight’s "Open-Angle Glaucoma - Epidemiology Forecast, 2027” report provides a comprehensive analysis of the Open-Angle Glaucoma epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2027.
Markets Covered • United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan
Study Period: 2016-2027
Open-Angle Glaucoma Epidemiology The epidemiology section covers the historical, current as well as forecasted epidemiology for Open-Angle Glaucoma in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Open-Angle Glaucoma outlook. It also includes the explanation of changing trends of epidemiology outlining the Open-Angle Glaucoma scenario.
Open-Angle Glaucoma Epidemiology Segmentation The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Open-Angle Glaucoma thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.
Report Scope • The report covers detailed overview of Open-Angle Glaucoma explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns • It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan • The Open-Angle Glaucoma Report assesses the disease risk and burden and highlights the unmet needs • It also helps to recognize the growth opportunities in the 7MM with respect to the patient population
Key strengths • 10 Year Forecast • 7MM Coverage • Total Cases in Open-Angle Glaucoma
Key assessments • Patient Segmentation in Open-Angle Glaucoma • Open-Angle Glaucoma Risk & Burden • Factors driving growth in a specific Open-Angle Glaucoma patient population
Our reports have been used by over 10K customers, including:
45 pages •
By Euromonitor International
• Oct 2018
Asia Pacific is witnessing the highest growth for spectacles globally with the region anticipated to overtake North America and become the second biggest market over the forecast period. Favourable demographics, rising aspiration levels among consumers and low penetration of spectacles are some of the key factors driving growth in this region. Euromonitor...
Strabismus Global Clinical Trials Review, H2, 2018 Summary GlobalData’s clinical trial report, “Strabismus Global Clinical Trials Review, H2, 2018" provides an overview of Strabismus clinical trials scenario.This report provides top line data relating to the clinical trials on Strabismus. Report...
185 pages •
By Transparency Market Research
• Aug 2018
Glaucoma Therapeutics Market: Scope and Methodology This report analyzes the current and future prospects of the global glaucoma therapeutics market.The report comprises a comprehensive executive summary, including a market snapshot that provides overall information of various segments. The research is a combination...
Comprehensive Pipeline Review on Ongoing Clinical and Pre-clinical studies Ocular Hypertension Drug Development Pipeline Study is the latest publication from VPA Research with comprehensive information of Ocular Hypertension pipeline products. The Ocular Hypertension pipeline guide presents complete overview of drugs currently...
Comprehensive Pipeline Review on Ongoing Clinical and Pre-clinical studies Atrophic Macular Degeneration Drug Development Pipeline Study is the latest publication from VPA Research with comprehensive information of Atrophic Macular Degeneration pipeline products. The Atrophic Macular Degeneration pipeline guide presents complete...
Comprehensive Pipeline Review on Ongoing Clinical and Pre-clinical studies Retinopathy Of Prematurity (RoP) Drug Development Pipeline Study is the latest publication from VPA Research with comprehensive information of Retinopathy Of Prematurity (RoP) pipeline products. The Retinopathy Of Prematurity (RoP) pipeline guide presents...